Skip to main content
  • Matters Arising
  • Open access
  • Published:

Reply to comment on “Ultrasonographic scores for ileal Crohn’s disease assessment: better, worse or the same as contrast‑enhanced ultrasound?

The Original Article was published on 05 August 2023


We read the comments by Nylund K et al. regarding our paper “Ultrasonographic scores for ileal Crohn’s disease assessment: Better, worse or the same as contrast‑enhanced ultrasound?”. Intestinal ultrasound has become one of the most valuable developments in the past decade, a non-invasive, well-tolerated exam, with an easy repeatability, and absence of sedation, ionizing radiation, or preparation. Particularly for inflammatory bowel disease, where there is a lack of agreement of patient’s symptoms with disease activity, in an era where the paradigm of mucosal healing is changing to transmural healing, and with the emergence of several therapies leading to repeated imaging surveillance, it is essential to highlight the role of intestinal ultrasound. Although intestinal ultrasound is an increasingly used tool to monitor inflammatory bowel disease activity, there is no widely accepted reproducible activity index, since the methodology for the development of the scores was shown to be insufficient in most studies and none have been adequately validated (Bots et al., J Crohns Colitis 12:920–9, 2018). In our study, we showed that the contrast-enhanced ultrasound (CEUS) peak enhancement derived from the time-intensity curve (TIC) is a promising non-invasive emerging method with a good accuracy to correlate clinical and endoscopic activity in the terminal ileum, superior to intestinal ultrasound scores relying on bowel wall thickness and colour Doppler.

Peer Review reports

We read the comments by Nylund K et al. [1] regarding our paper “Ultrasonographic scores for ileal Crohn’s disease assessment: Better, worse or the same as contrast‑enhanced ultrasound?”. In fact, our study aimed to compare, in our population, the accuracy of two intestinal ultrasound scores (SUS-CD score [2] and IBUS-SAS score [3]) and CEUS in predicting inflammatory activity in the terminal ileum in ileocolonoscopy in patients with Crohn’s disease, and not creating a score.

As pointed out by the authors, we recognize that the single-center, retrospective design of our study, and the selected population are limitations. We only included patients having an intestinal ultrasound, CEUS, and endoscopy, within 1 month, explaining the small sample of the study. Although we recognize that in clinical practice this may not occur in all the situations, we only included patients with these characteristics in order to limit potential bias regarding inflammatory activity variation. Regarding the reasons for which the assessment was performed we consider that this does not influence significantly the data as we are correlating endoscopic inflammatory activity with the ultrasound findings in the same subject.

Due to the retrospective design of our study we cannot use the concept “blinded” regarding the ultrasound operator to the results of the ileocolonoscopy. However, as mentioned in the text, we guarantee that the ultrasound operator was not the same that performed ileocolonoscopy examinations and the ileocolonoscopy examinations were performed after ultrasonographic examinations by an operator that does not have experience in ultrasound. Nevertheless, we recognize that, although the operator does not perform ultrasound, as a certified gastroenterologist he is able to interpret ultrasound findings.

Regarding the SES-CD threshold used in our study for inflammation, we highlight that there is no validated optimal SES-CD cut-off score and the quantification of disease severity has likewise not been standardized yet [4]. In our study, we graded the disease activity as inactive (normal or mild disease, with a SES-CD < 7) or active (moderate or severe disease, with a SES-CD ≥ 7), based on a previous study [5]. Several studies also considered this cut-off [6,7,8,9]. Although, some recent papers have used SES-CD with lower cut-offs, so we admit that the cut-off that we used (SES-CD ≥ 7) could be relatively high, and a lower value might have also been justified.

The authors highlighted that CEUS bowel wall perfusion measurements for detection of inflammation is only standard of care in select centers worldwide. However, in our center, we routinely perform CEUS in Crohn’s disease patients submitted to intestinal ultrasound as a part of a regular follow-up, including suspicion of active disease, assessment of remission or relapse, and monitoring of treatment effect. We recognize that it is a recent and promising tool, that needs more investigation, and that can contribute in clinical practice to the improvement of IBD activity monitoring. Evidence for the routine use of CEUS is based on small study groups and with significant methodological heterogeneity [10], with different ultrasound scanner and CEUS quantitative software, being the major issue for standardization, so there is still a need for large prospective studies that would help introducing the method into everyday practice.

In our paper a TIC curve based on wash-in wash-out is shown, not the fitted curve and the peak intensity was manually calculated.

Finally, we did not analyze inter-rater reliability as we only included ultrasonographic examinations performed by a single expert operator to uniformize the analysis. However, we agree that this is a major point for CEUS quantitative measurements, that needs to be addressed in future studies in order to demonstrate the reproducibility, and more objective character of CEUS.

Availability of data and materials

Not applicable.


  1. Nylund K, Novak K, Wilkens R. Matters arising: comment on “Ultrasonographic scores for ileal Crohn’s disease assessment: better, worse or the same as contrast‑enhanced ultrasound?”. BMC Gastroenterol 23:

  2. Sævik F, Eriksen R, Eide GE, Gilja OH, Nylund K. Development and validation of a simple ultrasound activity score for Crohn’s disease. J Crohns Colitis. 2021;15(1):115–24.

    Article  PubMed  Google Scholar 

  3. Novak KL, Nylund K, Maaser C, Petersen F, Kucharzik T, Lu C, et al. Expert consensus on optimal acquisition and development of the International Bowel Ultrasound Segmental Activity Score [IBUS-SAS]: a reliability and inter-rater variability study on intestinal ultrasonography in Crohn’s disease. J Crohns Colitis. 2021;15(4):609–16.

    Article  PubMed  Google Scholar 

  4. Klenske E, Bojarski C, Waldner M, Rath T, Neurath MF, Atreya R. Targeting mucosal healing in Crohn’s disease: what the clinician needs to know. Therap Adv Gastroenterol. 2019;12:1756284819856865.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Ripollés T, Martínez MJ, Paredes JM, Blanc E, Flors L, Delgado F. Crohn disease: correlation of findings at contrast-enhanced US with severity at endoscopy. Radiology. 2009;253(1):241–8.

    Article  PubMed  Google Scholar 

  6. Moskovitz DN, Daperno M, Van Assche GA, Baert F, Gevers A, Sostegni R, et al. Defining and validating cut-offs for the simple endoscopic score for Crohn’s disease. Gastroenterology. 2007;132(4):A173-A.

    Google Scholar 

  7. Sipponen T, Nuutinen H, Turunen U, Färkkilä M. Endoscopic evaluation of Crohn’s disease activity: comparison of the CDEIS and the SES-CD. Inflamm Bowel Dis. 2010;16(12):2131–6.

    Article  PubMed  Google Scholar 

  8. af Björkesten CG, Nieminen U, Turunen U, Arkkila P, Sipponen T, Färkkilä M. Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn’s disease. Scand J Gastroenterol. 2012;47(5):528–37.

    Article  PubMed  Google Scholar 

  9. Algaba A, Linares PM, Fernández-Contreras ME, Ordoñez A, Trápaga J, Guerra I, et al. Relationship between levels of angiogenic and lymphangi- ogenic factors and the endoscopic, histological and clinical activity, and acute-phase reactants in patients with inflammatory bowel disease. J Crohns Colitis. 2013;7(11):e569–79.

    Article  PubMed  Google Scholar 

  10. Serafin Z, Białecki M, Białecka A, Sconfienza LM, Kłopocka M. Contrast- enhanced ultrasound for detection of Crohn’s disease activity: systematic review and meta-analysis. J Crohns Colitis. 2016;10(3):354–62.

    Article  PubMed  Google Scholar 

Download references





Author information

Authors and Affiliations



M.F. wrote the main manuscript text. All authors reviewed the manuscript.

Corresponding author

Correspondence to Marta Freitas.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Freitas, M., de Castro, F.D., Silva, V.M. et al. Reply to comment on “Ultrasonographic scores for ileal Crohn’s disease assessment: better, worse or the same as contrast‑enhanced ultrasound?. BMC Gastroenterol 23, 266 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: